Buscar

Instrumento cobas p 480

Automatización de los pasos de preprocesamiento del vial primario

IVD For in vitro diagnostic use.
cobas p 480 instrument

Flujos de trabajo preanalíticos flexibles

El instrumento cobas p 480 es una solución autónoma sencilla y flexible que elimina las complicaciones asociadas a la manipulación manual de muestras. Automatiza las interacciones que requieren mucha mano de obra: permite a los técnicos centrarse en actividades más sofisticadas. Minimiza las posibilidades de contaminación de las muestras: aumenta la reproducibilidad de las muestras y la fiabilidad del proceso.

cobas p 480 Instrument
¿Tienes alguna pregunta?
Contacta con nosotros
Visión general del instrumento cobas p 480.
decapping
Destaponado

 

Quita los tapones de los tubos primarios para realizar pruebas en los sistemas cobas® 4800, 6800 u 8800

Hasta 1.536 muestras en un turno de 8 horas.

Ver el vídeo

cobasP480_Carousel_Images_recapping
Recapitulación

 

Vuelve a tapar los viales de muestras con tapones nuevos para evitar la contaminación

Hasta 1.536 muestras en un turno de 8 horas

aliquoting
Alícuota

 

Alícuota volúmenes configurables de viales primarios PreservCyt®, SurePath™ y cobas® PCR Cell Collection Media en tubos secundarios con código de barras coincidente.


Hasta 672 muestras en un turno de 8 horas

Ver el vídeo

reagent addition & heating
Adición de reactivos y calentamiento

 

Adición de tampón de preparación de muestras cobas® e incubación de las muestras recogidas en SurePath™medium para invertir la reticulación y liberar los ácidos nucleicos para las pruebas1,*.

Hasta 1.536 muestras en un turno de 8 horas.

 

Ver el vídeo

Proceso de reticulación

Ver el vídeo

Prevención avanzada de la contaminación

El instrumento cobas p 480 utiliza una combinación de controles físicos, de software y basados en procesos para garantizar la confianza en la integridad de las muestras y los resultados.

Tecnologías avanzadas de manipulación de líquidos

RMD_07-CO-RE-Tip_O-RIng_molecular_new

Tecnología de punta de expansión de junta tórica comprimida (CO-RE)

 

Reduce la producción de aerosol durante la expulsión de la punta

TADM

Monitorización total de aspiración y dispensación (TADM)

 

Supervisión en tiempo real de los pasos de aspiración y dispensación

Ver el vídeo

pressure_time_smaller

Control antigoteo (ADC)

 

Supervisa continuamente la presión del canal de pipeteo y la ajusta en tiempo real

Software y controles de procesos

Consiga fiabilidad en el proceso y un seguimiento completo de los datos con el software intuitivo y los controles de proceso del instrumento cobas p 480. Con un software fácil de usar y una interfaz sencilla e intuitiva, puede mantener sus procesos preanalíticos bajo control total.

  • Seguimiento de la cadena de custodia de las muestras mediante correspondencia de códigos de barras
  • Seguimiento mediante código de barras de todas las muestras, reactivos y consumibles
  • La avanzada tecnología de pipeteo reduce las posibilidades de contaminación para garantizar la integridad de las muestras
  • Los informes imprimibles capturan los ID de las muestras, los errores de las muestras y la información sobre el lote y la caducidad de los reactivos
Eficacia preanalítica

El instrumento cobas p 480 mejora la eficiencia del laboratorio al permitir que el valioso tiempo de los técnicos se utilice de forma más productiva, eliminando la manipulación manual y repetitiva de las muestras, mejorando el flujo de trabajo y reduciendo el riesgo de contaminación, errores humanos y lesiones en el lugar de trabajo.

Información relacionada

Insertos para envases

Acceda a los folletos de los envases a través del sitio web de Roche Diagnostics de tu país.

Puede interesarte

...
    ...

    *La automatización del procedimiento de pretratamiento SurePath™ con el instrumento cobas p 480 no ha sido revisada por la FDA y no está aprobada en Estados Unidos.

     

    Referencias

    1. Kiernan JA. Preservation and retrieval of antigens for immunohistochemistry—methods and mechanisms. Part 2: Retrieving masked antigens. http://publish.uwo.ca/~jkiernan/FixAnti2.pdf. Accessed December 20, 2016. The Cutting Edge. 2005:5-11.

    Resumen

    Pedidos

    Documentos técnicos

    multilangimg
       
    Acceso a eLabDoc
    Country Specific Labeling See country-specific product labeling for regulatory status.
    Imagen de producto para el sistema LightCycler® 96
    LightCycler® 96 Instrument The LightCycler® 96 Instrument is a real-time PCR system for rapid cycling up to 96 samples. Applications include absolute and relative quantification, qualitative detection, melting curve analysis, high resolution melting and endpoint genotyping. Precise LightCycler® 96 Instrument thermal homogeneity and cycling speed produce accurate and reproducible results in a very short time. The LightCycler® 96 Instrument's optical detection system flexibly detects sequence-dependent probes, such as hydrolysis probes and sequence-independent dyes (i.e., SYBR Green I). Multiplex and multicolor capabilities permit the use of up to four different fluorescent dyes. New innovative LightCycler® 96 Application and Instrument Software creates a simple analysis workflow with easy import and export functions, email notifications after each run, online monitoring flexibility, and server-based network interfacing.
    IVD For in vitro diagnostic use.
    Product image for MagNA Pure 24 System
    MagNA Pure 24 Instrument A fully-automated clinical nucleic acid extraction system that brings you walkaway automation for up to 24 samples. The MagNA Pure 24 System is a fully automated clinical sample extractor. It extracts nucleic acids from various sample types, sample tubes, and volume inputs for multiple downstream applications.The main features of the system are:Scalable purification of 1 to 24 samplesPrimary/secondary tube handlingInventory and sample management via barcodesEfficient order management via host
    IVD For in vitro diagnostic use.
    Sistema MagNA Pure 96
    MagNA Pure 96 Instrument High-throughput robotic workstation for fully automated purification of nucleic acids from up to 96 samples. Magnetism is the underlying principle of the automated nucleic acid isolation performed by the highthroughput MagNA Pure 96 System. The MagNA Pure 96 Instrument performs automated nucleic acid purification from samples of up to 1000 μl that are pipetted into a 96-well processing cartridge. It comprisesa magnetic glass particles (MGP) based purification process as well as protocols that support isolation of RNA, DNA and tNA from different sample materials. The MagNA Pure 96 System permits automated nucleic acid purification that matches the high standards of speed, accuracy and reliability in PCR/ RT-PCR of the LightCycler® Systems.
    IVD For in vitro diagnostic use.
    Sistema cobas® 5800
    cobas® 5800 System The cobas® 5800 system supports an automated and integrated workflow to run polymerase chain reaction (PCR) based nucleic acid testing (NAT) for use by trained professionals in laboratory settings. The cobas® 5800 system combines the functionalities of instrumentation, consumables, reagents, and data management to provide an efficient workflow from sample processing to result interpretation.
    IVD For in vitro diagnostic use.
    <b>cobas</b><sup>®</sup> 6800 System
    cobas® 6800 System The cobas® 6800/8800 Systems support an automated and integrated workflow to run Polymerase Chain Reaction (PCR) based Nucleic Acid Testing (NAT).The cobas® 6800/8800 Systems combine the functionalities of instrumentation, consumables, reagents, and data management to provide an efficient workflow from sample processing to result interpretation.
    IVD For in vitro diagnostic use.
    Sistema cobas® 8800
    Sistema cobas® 8800 Ejecuta hasta 1056 pruebas en un turno de 8 horas y experimenta una automatización sin precedentes: solo 3 interacciones de usuario por ejecución durante un máximo de 4 horas de tiempo de autonomía operativa.
    IVD For in vitro diagnostic use.
    Sistema preanalítico cobas® prime
    cobas® prime pre-analytical system Content was migrated to RDK.
    IVD For in vitro diagnostic use.
    <b>cobas</b><sup>®</sup> Cdiff
    cobas® Cdiff Nucleic acid test for use on the cobas® liat system Provide accurate, on-demand results in 20 minutes for the detection of toxigenic C. diff with the POC PCR test for use on the cobas® liat system.
    GLU For general laboratory use.
    Solución FLOW
    FLOW Solution FLOW Flex For cost efficiencyStart simple by combining primary sample handing and PCR setup in a single instrument:Up to 288 samples and 1,400 results per day*Easily add additional devices as throughput increasesSample handling and PCR setup as a combined system for cost and space efficiencyIntegrated software connecting instrument workflow to your lab’s LISNon-linear workflowFLOW Classic For high throughputPlan for expansion by utilizing dedicated instruments for sample handling and PCR setup:Up to 384 samples and 1,900 results per day*Add additional instruments as throughput increases—up to 1,000 samples and 5,000 test results per dayTwo pipetting instruments for high throughput efficiencyIntegrated software connecting instrument workflow to your lab’sLIS Linear workflow
    IVD For in vitro diagnostic use.
    ePlex<sup>® </sup>system
    ePlex® system The ePlex system is used to run multiplex microarray-based assays developed by GenMark. This type of assay is based on the principles of competitive nucleic acid hybridization using a sandwich assay format, wherein a single-stranded target binds concurrently to a sequence-specific solution-phase signal probe and a solid-phase electrode-bound capture probe. The test employs nucleic acid extraction, target amplification via polymerase chain reaction (PCR) or reverse transcription PCR (RT-PCR) and hybridization of target DNA. In the process, the double-stranded PCR amplicons are digested with exonuclease to generate single-stranded DNA suitable for hybridization.
    IVD For in vitro diagnostic use.
    <b>cobas</b><sup>®</sup> 4800 system
    cobas® 4800 system The cobas® 4800 System is intended to be used as an in vitro diagnostics system providing sample preparation, amplification and detection of specific targets from human samples. It integrates fully automated total nucleic acid isolation directly from primary and secondary tubes, automated PCR setup, and real time PCR.
    IVD For in vitro diagnostic use.
    Sistema cobas s 201
    cobas® s 201 system The cobas s 201 system is a complete NAT solution supporting the central needs of blood screening labs, combining the efficiency and reliability of real-time PCR technology with modular automation, ready-to-use reagents and a robust menu selection.
    IVD For in vitro diagnostic use.
    1
    cobas® SARS-CoV-2 & Influenza A/B v2 Qualitative nucleic acid test for use on the cobas® 5800/6800/8800 Systems cobas® SARS-CoV-2 & Influenza A/B v2 assay for use on the cobas® 5800/6800/8800 Systems (cobas® SARS-CoV-2 & Influenza A/B v2) is an automated multiplex real-time RT-PCR assay intended for simultaneous qualitative detection and differentiation of SARS-CoV-2, influenza A virus, and/or influenza B virus RNA in healthcare provider-collected nasal and nasopharyngeal swab specimens, and self-collected nasal swab specimens (collected in a healthcare setting with instruction by a healthcare provider) from individuals suspected of respiratory viral infection consistent with COVID-19 by their healthcare provider. cobas® SARS-CoV-2 & Influenza A/B v2 is intended for use as an aid in the differential diagnosis of SARS-CoV-2, influenza A, and influenza B in humans and is not intended to detect influenza C.RNA from SARS-CoV-2, influenza A, and influenza B is generally detectable in respiratory specimens during the acute phase of infection. Positive results are indicative of the presence of SARS-CoV-2, influenza A, and/or influenza B RNA; clinical correlation with patient history and other diagnostic information is necessary to determine patient infection status. Positive results do not rule out bacterial infection or co-infection with other viruses. The agent detected may not be the definite cause of disease.Negative results do not preclude infection from SARS-CoV-2, influenza A, and/or influenza B and should not be used as the sole basis for treatment or other patient management decisions. Negative results must be combined with clinical observations, patient history, and epidemiological information.cobas® SARS-CoV-2 & Influenza A/B v2 is intended for use by qualified clinical laboratory personnel specifically instructed and trained in the techniques of real-time PCR and on the use of the cobas® 5800/6800/8800 Systems.
    IVD For in vitro diagnostic use.
    <b>cobas</b><sup>®</sup> <b>liat</b> system
    cobas® liat system The cobas® liat analyzer is an automated nucleic acid test instrument, that when used together with cobas® liat assay tubes to perform in vitro diagnostic tests, is referred to as the cobas® liat system. In conjunction with a cobas® liat assay tube, the instrument performs reagent preparation, target enrichment, inhibitor removal, nucleic acid extraction, polymerase chain reaction (PCR) amplification, real-time detection, and result interpretation to automate the detection or quantification of nucleic acid targets in a biological sample.Addition for Canada only:The cobas® liat system is intended for professional use in a clinical laboratory setting or Point of Care (POC) location.
    error errorMessage
    Se ha producido un problema al cargar esta sección.
    Vuelve a cargar esta página o inténtalo de nuevo más tarde.
    © 2024 F. Hoffmann-La Roche Ltd
    Esta web está destinada a profesionales de la salud que ejercen su profesión en España y/o Andorra. La información se proporciona con fines generales y en caso de que no sea un profesional de la salud y requiera un diagnóstico o información médica completa, deberá dirigirse a su médico o profesional sanitario. ROCHE controla y utiliza este sitio web en España y Andorra y no puede garantizar que los datos del mismo sean correctos o estén disponibles en otros países, por lo tanto, ROCHE le advierte que este sitio web podría contener detalles de productos o información no accesible por otras vías o no válida en su país. Rogamos sea consciente de que declinamos cualquier responsabilidad en el caso de que acceda a información que no se ajuste a las disposiciones legales, reglamentos o uso en su país de origen.